Evidence map›Paper›PMID 32964167›Full record

ArticleVeterinary and animal science2020

Tildipirosin: An effective antibiotic against Glaesserella parasuis from an in vitro analysis.

Priscila Rodrigues Peres, Simone Ramos Prigol, César Bernardo Gutiérrez Martín, César Feronatod, Miquel Collell Suriñach, Luiz Carlos Kreutz, Rafael Frandoloso

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary and animal science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Brazilian Clinical Strains ofAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Priscila Rodrigues PeresAFK Imunotech, Passo Fundo, 99052-900, Brazil.
Simone Ramos PrigolAFK Imunotech, Passo Fundo, 99052-900, Brazil.
César Bernardo Gutiérrez MartínMicrobiology and Immunology Unit, Department of Animal Health, Faculty of Veterinary Medicine, University of León, León, 24007, Spain.
César FeronatodMSD-Merck Animal Health, Madison, 7940, USA.
Miquel Collell SuriñachMSD-Merck Animal Health, Madison, 7940, USA.
Luiz Carlos KreutzLaboratory of Microbiology and Advanced Immunology, Faculty of Agronomy and Veterinary Medicine, University of Passo Fundo (UPF), Passo Fundo, 99052-900, Brazil.
Rafael FrandolosoLaboratory of Microbiology and Advanced Immunology, Faculty of Agronomy and Veterinary Medicine, University of Passo Fundo (UPF), Passo Fundo, 99052-900, Brazil.
Universidade de Passo Fundo · BRUniversidad de León · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tildipirosin is a latest generation macrolide that is used to battle infection diseases caused by Gram-negative bacteria. Recent studies have shown the effectiveness of this antimicrobial agent against

Indexed as

Glaesserella parasuisGlässer's diseaseMinimal inhibitory concentrationPigTildipirosin

Identifiers

PMID32964167
PMCPMC7487419
OpenAlexW3044337101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.